Tau PET in CAA, by contrast, has primarily been applied to characterize co-existing neurodegenerative pathology, with emerging evidence indicating that regional tau burden is more closely related to cognitive impairment than to hemorrhagic risk, supporting its complementary and exploratory role in CAA phenotyping [30]. Here, MAPT is linked to Cognitive impairment.